Foot (Edinburgh, Scotland) · 2026
Proximal medial gastrocnemius release: Loosening the calf, tightening the criteria for its use.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Poutoglidou Freideriki, Elliot Robin, Dimock Richard
Аннотация
BACKGROUND: Restricted ankle dorsiflexion from gastrocnemius tightness contributes to multiple foot and ankle disorders. Proximal medial gastrocnemius release (PMGR), originally developed for spasticity, is increasingly used for adult pathologies, yet its indications and outcomes remain debated.
METHODS: We performed a contemporary review of PubMed, EMBASE, and CENTRAL up to January 2025, including clinical and biomechanical studies on PMGR in adults. Non-English, pediatric, distal gastrocnemius releases, and non-original articles were excluded.
RESULTS: The Silfverskiöld and lunge tests remain the main diagnostic tools, though no standardized protocol exists. PMGR appears safe, with rare minor complications, and generally preserves calf strength. Evidence supports its role in plantar fasciitis with durable pain and function improvements. For Achilles tendinopathy, metatarsalgia, and progressive collapsing foot deformity, only small case series exist. Data for neuropathic ulcers and hallux deformities are sparse and inconclusive.
CONCLUSIONS: PMGR is effective for plantar fasciitis, but current evidence is limited and heterogeneous for other conditions. High-quality trials are required to define its broader role.
LEVEL OF EVIDENCE: Level IV, therapeutic review.
METHODS: We performed a contemporary review of PubMed, EMBASE, and CENTRAL up to January 2025, including clinical and biomechanical studies on PMGR in adults. Non-English, pediatric, distal gastrocnemius releases, and non-original articles were excluded.
RESULTS: The Silfverskiöld and lunge tests remain the main diagnostic tools, though no standardized protocol exists. PMGR appears safe, with rare minor complications, and generally preserves calf strength. Evidence supports its role in plantar fasciitis with durable pain and function improvements. For Achilles tendinopathy, metatarsalgia, and progressive collapsing foot deformity, only small case series exist. Data for neuropathic ulcers and hallux deformities are sparse and inconclusive.
CONCLUSIONS: PMGR is effective for plantar fasciitis, but current evidence is limited and heterogeneous for other conditions. High-quality trials are required to define its broader role.
LEVEL OF EVIDENCE: Level IV, therapeutic review.